Ben Woolven
Consultant / Advisor at Resolution Therapeutics Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harry Dietz | M | 66 | 2 years | |
| Martin Murphy | M | 55 |
Resolution Therapeutics Ltd.
 Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom.
University of Cambridge
| 4 years |
| Hal Barron | M | 62 | 6 years | |
| Charles Bancroft | M | 65 | 4 years | |
| Anne Beal | M | 62 | 3 years | |
| Tony Wood | M | - | 7 years | |
| Jesse Goodman | M | 72 | 8 years | |
| Jonathan Symonds | M | 66 | 5 years | |
| Shobie Ramakrishnan | F | - | 6 years | |
| Anne-Marie Martin | M | 52 | 4 years | |
| Kate Butler | F | - |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | 2 years |
| Stuart Forbes | M | 57 |
Resolution Therapeutics Ltd.
Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | - |
| Diana Conrad | F | - | 8 years | |
| Maya Martinez-Davis | F | 54 | 4 years | |
| Regis Jean-Pierre Simard | M | 59 | 6 years | |
| Gwenaelle Pemberton | F | - |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | 2 years |
| John Campbell Robertson | M | 73 |
University of Cambridge
| 30 years |
| Lisa Bright | F | 56 |
Resolution Therapeutics Ltd.
Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | - |
| Luke Miels | M | - | 7 years | |
| Dame Dowling | M | 71 |
University of Cambridge
| 31 years |
| Gehan Anil Joseph Amaratunga | M | - |
University of Cambridge
| 28 years |
| Mick Readey | M | - | 3 years | |
| Edward Hodgkin | M | 61 |
Resolution Therapeutics Ltd.
Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | 4 years |
| Michael Elmore | M | - | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Moncef Slaoui | M | 64 | 11 years | |
| Philip Hampton | M | 70 | 4 years | |
| Amit K Shah | M | - |
University of Cambridge
| 6 years |
| Andrew Witty | M | 59 | - | |
| Thomas Mount | M | - | 7 years | |
| Stephanie Burns | M | 69 | 9 years | |
| Anjali Bansal | F | 53 | 6 years | |
| Johnson Chen | M | 53 |
University of Cambridge
| 5 years |
| Michael Edward John Phelps | M | - |
University of Cambridge
| 5 years |
| Sarah Elton-Farr | F | - | 4 years | |
| Robert Welna | M | - |
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | 5 years |
| Lisa M. Kreiling | M | - |
University of Cambridge
| 5 years |
| John Slater | M | 51 |
University of Cambridge
| 5 years |
| Iain Mackay | M | 62 | 4 years | |
| Jeremy Tan | M | - |
University of Cambridge
| 3 years |
| Jing Ulrich | F | 57 | - | |
| Guy Cavet | M | 50 |
University of Cambridge
| 8 years |
| Basil Lui | M | - |
University of Cambridge
| 4 years |
| Wing Hoy Tsang | M | 55 |
University of Cambridge
| 8 years |
| William Louv | M | - | 21 years | |
| Neil Brewis | M | 57 |
Domantis Ltd.
Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | 13 years |
| Choon Wui Lim | M | 53 |
University of Cambridge
| 6 years |
| Sofia Maroudia | F | 47 |
University of Cambridge
| 7 years |
| Mohammed Abdelmoez M. Jamil Al-Mohtaseb | M | 49 |
University of Kent
| 6 years |
| Murray Stewart | M | 63 | 17 years | |
| Balbir Kelly Bisla | F | - | 4 years | |
| Ravi Rao | M | 55 | 7 years | |
| Jason Wulfsohn | M | 52 |
University of Cambridge
| 4 years |
| Edward King | M | 50 |
University of Cambridge
| 4 years |
| Xiao Hong Xi | M | 61 |
University of Cambridge
| 7 years |
| Robert Carr | M | - | 26 years | |
| Zoe Nakash | F | - |
University of Cambridge
| 4 years |
| Philip Cowans | M | - |
University of Cambridge
| 8 years |
| Iain Kilty | M | - |
University of Cambridge
| 4 years |
| Roy Anderson | M | 76 | 11 years | |
| Simon Dingemans | M | 61 | 8 years | |
| Rumi Masih | M | - |
University of Cambridge
| 5 years |
| Judy Lewent | F | 75 | 10 years | |
| H. Culp | M | 60 | 9 years | |
| Laurie Glimcher | M | 72 | 5 years | |
| Deryck Charles Maughan | M | 76 | 12 years | |
| Robert Wilson | M | 81 | 11 years | |
| Christopher Gent | M | 75 | 11 years | |
| Adrian John Cronje | M | - |
University of Cambridge
| 4 years |
| James Murdoch | M | 50 | 3 years | |
| Crispin Davis | M | 75 | 10 years | |
| Stacey Cartwright | F | 60 | 5 years | |
| Tom de Swaan | M | 78 | 9 years | |
| Andrew O'Neill | M | - |
University of Cambridge
| 3 years |
| Gerardus Johannes Wijers | M | 74 | 3 years | |
| Dame Cox | F | 64 | 6 years | |
| Ka-lai Cheng | F | 45 |
University of Cambridge
| 4 years |
| Vindi Banga | M | 69 | 7 years | |
| Ting Min Tan | F | 55 |
University of Cambridge
| 7 years |
| Urs Rohner | M | 65 | 9 years | |
| Daniel Podolsky | M | 70 | 10 years | |
| Saul Charles Klein | M | 53 | 2 years | |
| Lynn Elsenhans | F | 68 | 10 years | |
| Ian Tomlinson | M | - |
Domantis Ltd.
Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | 6 years |
| Jonathan Aberman | M | - |
University of Cambridge
| 8 years |
| Simon Holden | M | 48 |
University of Cambridge
| 5 years |
| Jennifer Suman | F | - |
University of Cambridge
| 3 years |
| Sonny Bardhan | M | - |
University of Cambridge
| 4 years |
| Tim Rule | M | - |
University of Cambridge
| 3 years |
| Alexandra Maddy | F | - |
University of Cambridge
| 3 years |
| Sifelani Thapelo | M | 59 |
University of Cambridge
| 3 years |
| Boo Yeow Khoo | M | 52 |
University of Cambridge
| 3 years |
| Daniel Edwards | M | - |
University of Cambridge
| 4 years |
| Jonathan Sheldon | M | 52 |
University of Cambridge
| 3 years |
| Andy Bloxam | M | - |
University of Cambridge
| 3 years |
| Chirstopher David Kingsman | M | 49 |
University of Cambridge
| 4 years |
| Jhu Hwa Tan | M | 50 |
University of Cambridge
| 4 years |
| Simon Crosby | M | - |
University of Cambridge
| 4 years |
| George Chamberlain | M | - |
University of Cambridge
| 4 years |
| Kushal Shah | M | - |
University of Cambridge
| 3 years |
| Aiden Lewis Bantin | M | - |
University of Cambridge
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ben Woolven
- Personal Network
